The reduction of MASP-2 serum levels in RA patients could also be due to hormonal alterations, such as from thyroid and growth hormones, and acute phase response, since the expression of some complement proteins can be influenced by these conditions [46], [47]. This evidence concerns the gene VTN and rheumatoid arthritis.